Variability in platelet procoagulant activity inhealthy volunteers

Thrombosis Research

Volumn 81, Issue 5, 1996, Pages 533-543

  Sumner, William T ^b   Monroe, Dougald M ^b   Hoffman, Maureane ^a  

^a DURHAM VA MEDICAL CENTER   (United States)

^b NONE

Author keywords

Blood coagulation; Factor Xa; Flow Cytometry; Phosphatidylserine; Thrombin

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9A; PHOSPHATIDYLSERINE; THROMBIN;

ADULT; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION;

ADULT; BLOOD COAGULATION FACTORS; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PHOSPHATIDYLSERINES; PLATELET ACTIVATION; REFERENCE VALUES; THROMBOPLASTIN;

EID: 0029939917     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(96)00028-X     Document Type: Article

References (25)

1. Mann KG, Nesheim ME, Church WR, Haley P, Krishnaswamy S. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood 76, 1-16, 1990.
2. Bevers EM, Tilly RH, Senden JM, Comfurius P, Zwaal RF. Exposure of endogenous phosphatidylserine at the outer surface of stimulated platelets is reversed by restoration of aminophospholipid translocase activity. Biochemistry 28, 2382-2387, 1989.
3. Rosing J, van Rijn JLML, Bevers EM, van Dieijen G, Comfurius P, Zwaal RFA. The role of activated human platelets in prothrombin and factor X activation. Blood 65, 319-32, 1985.
4. Comfurius P, Senden JM, Tilly RH, Schroit AJ, Bevers EM, Zwaal RF. Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. Biochim Biophys Acta 1026, 153-60, 1990.
5. Connor J, Bucana C, Fidler IJ, Schroit AJ. Differentiation-dependent expression of phosphatidylserine in mammalian plasma membranes: quantitative assessment of outer-leaflet lipid by prothrombinase complex formation. Proc Natl Acad Sei U S A 86, 3184-8, 1989.
6. Bode AP, Sandberg H, Dombrose FA, Lentz BR. Association of factor V activity with membranous vesicles released from human platelets: Requirement for platelet activation. Thromb Res 39, 49-61, 1985.
7. Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem 264, 17049-57, 1989.
8. Crook M, Machin SJ, Crawford N. Basal and induced prothrombinase expression in platelets from patients with essential thrombocythaemia. Br J Haematol 76, 256-259, 1990.
9. Jenny R, Church WR, Odegaard B, Litwiller R, Mann KG. Purification of six human vitamin K-dependent proteins in a single chromatographic step using immunoaffinity columns. Prep. Biochem. 16, 227-45, 1986.
10. Church FC, Whinna HC. Rapid sulfopropyl-disk chromatographic purification of bovine and human thrombin. Anal. Biochem. 157, 77-83, 1986.
11. Monroe DM, Sherril GB, Roberts HR. Use of p-aminobenzamidine to monitor activation of trypsin-like serine proteases. Analyt Biochem 172, 427-435, 1988.
12. McCord DM, Monroe DM, Smith KJ, Roberts HR. Characterization of the functional defect in factor IX Alabama. J Biol Chem 265, 10250-4, 1990.
13. Monroe DM, Roberts HR, Hoffman M. Platelet procoagulant complex assembly in a tissue factor-initiated system. Br J Haematol 88, 364-371, 1994.
14. Hoffman M, Monroe DM, Roberts HR. Coagulation factor IXa binding to activated platelets and platelet-derived microparticles: a flow cytometric study. Thromb Haemost 68, 74-8, 1992.
15. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84, 1415-20, 1994.
16. Dachary-Prigent J, Freyssinet J-M, Pasquest J-M, Carron J-C, Nurden AT. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: A flow cytometry study showing a role for free sulfhydryl groups. Blood 81, 2554-65, 1993.
17. Dawson-Saunders B, Trapp RG. In: Lange A, ed. Basic and Clinical Biostatistics. New York, 1990; 163-166.
18. Monkovic DD, Tracy PB. Functional characterization of human platelet-released factor V and its activation by factor Xa and thrombin. J Biol Chem 265, 17132-40, 1990.
19. Kane WH, Mruk JS, Majerus PW. Activation of coagulation factor V by a platelet protease. J Clin Invest 70, 1092-100, 1982.
20. Funakoshi T, Heimark RL, Hendrickson LE, McMullen BA, Fujikawa K. Human placental anticoagulant protein: Isolation and characterization. Biochemistry 26, 5572-5578, 1987.
21. Ravanat C, Archipoff G, Beretz A, Freund G, Cazenave JP, Freyssinet JM. Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells. Biochem J 282, 7-13, 1992.
22. Tait JF, Gibson D, Fujikawa K. Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family. J Biol Chem 264, 7944-7949, 1989.
23. Nesheim ME, Furmaniak-Kazmiercsak E, Henin C, Cote G. On the existence of platelet receptors for factor V(a) and factor VIII(a). Thromb Haemostas 70, 80-86, 1993.
24. Nesheim ME, Pittman DD, Wang JH, Slonosky D, Giles AR, Kaufman RJ. The binding of 35S-labeled recombinant factor VIII to activated and unactivated human platelets. J Biol Chem 263, 16467-70, 1988.
25. Ahmad SS, Rawala-Sheikh R, Walsh PN. Comparative interactions of factor IX and factor IXa with human platelets. J Biol Chem 264, 3244-3251, 1989.